CalciMedica, Inc. (CALC) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for CalciMedica, Inc. (CALC).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $2.83

Daily Change: -$0.17 / 6.01%

Daily Range: $2.81 - $3.00

Market Cap: $40,658,520

Daily Volume: 20,771

Performance Metrics

1 Week: -15.41%

1 Month: 80.75%

3 Months: 45.50%

6 Months: 9.81%

1 Year: -32.01%

YTD: -17.80%

Company Details

Employees: 14

Sector: Health technology

Industry: Biotechnology

Country:

Details

CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops Auxora for the treatment of acute ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory indications. The company is based in La Jolla, California.

Selected stocks

Adverum Biotechnologies, Inc. (ADVM)

Onconetix, Inc. (ONCO)

SiNtx Technologies, Inc. (SINT)